试验透明度

As an essential part of our clinical trial governance, we are committed to elevating your experience with constant communication and data transparency.

Open communication

Collaborative and proactive, our research teams prioritize open communication with stakeholders throughout trials to help you make the right decisions at the right time.

Clarity

We use data and technology to provide personalized, transparent experiences.

Our proprietary technology Clarity is used as standard across all trials we support and fits seamlessly into your existing workflow so you can see how your study is progressing and how your patient data is performing. It does this through simplified data collection with EDC to CTMS to safety database integration and a continuous flow of information that enables data transparency and a secure, holistic view of your clinical study progress near real-time.

This holistic view allows integrated teams within Caidya to transparently share information and data, generating and sharing insights to inform your decisions.

Learn more about Clarity
Gateway to the globe

Speak to a global expert

Discover how our technology and data integration solutions help you safely and efficiently progress your clinical studies with confidence.

了解团队>联系
引领创新

Caidya新闻

探索关于我们释放临床研究潜能更多信息

News

11/09/22

康缔亚(Caidya)宣布任命 Barbara Lopez Kunz 为董事会成员

上海和北卡罗来纳州莫里斯维尔,2022 年 11 月 10 日 – 康缔亚是一家提供多治疗领域临床研究服务的CRO(临床研究合同组织),致力于高质量交付和提升客户体验。公司今天宣布任命Barbara Lopez Kunz为公司董事会成员,该任命自 2022 年 11 月 1 日起生效。 Kunz女士加入康缔亚董事会,她目前为DIA(药物信息协会)全球总裁兼首席执行官。DIA是一个全球性会员型组织,旨在推动生命科学和医疗保健专业人士以改善全球的健康和福祉。自 2013 年上任以来,Kunz女士出色地搭建和推动了...

News

10/03/22

dMed | Clinipace announce corporate name change to Caidya

SHANGHAI and MORRISVILLE, N.C., October 3, 2022 – dMed | Clinipace, ...